FDA Clearance Tracker · P960011-S009
BIOLON (1% SODIUM HYALURONATE FOR OPHTHALMIC SURGERY)
Last checked: Nov 20, 2026Latest source record: Jan 27, 2005 (this decision)Source: openFDAMethods & limitations
Decided
Jan 27, 2005
Approved
Time to decision
202 days
Received Jul 9, 2004. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P960011-S009
- Device name
- BIOLON (1% SODIUM HYALURONATE FOR OPHTHALMIC SURGERY)
- Applicant
- Altacor , Ltd.
- Applicant location
- Theale
- Received
- Jul 9, 2004
- Decided
- Jan 27, 2005
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P960011
Device type
- Device type
- AID, SURGICAL, VISCOELASTIC (LZP)
- Device class
- Class III
- Regulation
- 21 CFR 886.4275
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR A CHANGE IN MANUFACTURING SITE TO THE BIO-TECHNOLOGY GENERAL, LTD. FACILITY IN BE'ER TUVIA, ISRAEL, AND FOR A CHANGE IN THE SPECIFICATIONS FOR THE ACTIVE PHARMACEUTICAL PRODUCT IN BIOLON.
Source documents
Other decisions for Altacor , Ltd.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.